The increased PKM1 level in HLCS knockdown could attenuate cancer growth, as reported in prostate adenocarcinoma, where inhibiting receptor tyrosine kinase signaling induces the expression of PKM1 and attenuates the growth of glioblastoma (Yang et al., 2022). This evidence concerns the gene NTRK1 and prostate adenocarcinoma.